Investor malaise stalks UK, European biotech

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: London biotech stocks (BioCentury London Index, the combined market capitalization for 14 bioscience stocks listed on the London Stock Exchange (LSE) or LSE's Alternative Investment Market (AIM)) versus FTSE 100 (Financial Times Stock Exchange 100 stock index).

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading